Correlation Between Viking Therapeutics and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Viking Therapeutics and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Vertex Pharmaceuticals.
Diversification Opportunities for Viking Therapeutics and Vertex Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Viking and Vertex is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Vertex Pharmaceuticals
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 5.48 times more return on investment than Vertex Pharmaceuticals. However, Viking Therapeutics is 5.48 times more volatile than Vertex Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 809.00 in Viking Therapeutics on September 12, 2024 and sell it today you would earn a total of 3,976 from holding Viking Therapeutics or generate 491.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Viking Therapeutics |
| Vertex Pharmaceuticals |
Viking Therapeutics and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Vertex Pharmaceuticals
The main advantage of trading using opposite Viking Therapeutics and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |